Skip to main content
logo
Galera Therapeutics, Inc. (GRTXD)
OTCMKTS · Delayed Price · Currency is USD
18.99
0.00 (0.00%)
Inactive · Last trade price on Aug 3, 2026

Galera Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
16251161173
Market Cap Growth
731.25%-51.98%-56.28%-81.38%-65.01%-52.46%
Enterprise Value
151521481351885
Last Close Price
15.626.2713.0541.43424.561307.88

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
0.120.04----
PB Ratio
3.230.36-0.03-0.09-0.55-2.98
P/TBV Ratio
22.320.60----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---1.05-1.16-1.28-2.21
Net Debt / Equity Ratio
-1.09-0.97-0.99-1.02-0.99-0.98
Net Debt / EBITDA Ratio
-1.06-10.10-2.87-2.12-0.79
Net Debt / FCF Ratio
1.171.05-11.75-2.98-2.49-0.84
Quick Ratio
4.829.885.363.682.605.51
Current Ratio
5.3111.006.004.362.885.98
Return on Assets (ROA)
-51.84%-43.66%-48.81%-83.63%-50.28%-54.78%
Return on Capital Employed (ROCE)
-114.20%-92.20%-167.80%-221.60%-167.10%-104.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
390.96%6301.62%-384.84%-524.36%-102.85%-46.58%
FCF Yield
-28.84%-255.74%-246.55%-398.56%-71.82%-39.47%
Buyback Yield / Dilution
-50.02%-80.30%-22.64%-64.47%-5.03%-3.70%